In a study published in AIDS Research and Therapy, Ph.D. candidate Thinh Vu explores the temporal trends in the time from HIV diagnosis to the initiation of antiretroviral therapy (ART) across the ...

A preliminary study has found that efavirenz — a non-nucleoside inhibitor of HIV virus that is used for treating HIV/AIDS — can be repurposed for the treatment of chikungunya. Currently ...

Nearly 85% of the 1.7 million adolescents with HIV live in sub-Saharan Africa, along with half of the nearly 40 million ...

Among the signatories was French scientist Francoise Barre-Sinoussi, who won a 1983 medicine Nobel prize for her work identifying the HIV virus. The US government has said the funding cuts were ...

Groundbreaking South African HIV cure trial shows 20% of participants maintaining viral suppression without medication for 18 months, marking a significant milestone in HIV research.

Physicians and their patients report that engagement in an HIV-based community rivals drug effectiveness in the ongoing efforts to curtail an epidemic. Confronting the HIV Epidemic: There's an App ...

With the acute phase of the Covid-19 pandemic fading even as the coronavirus persists and evolves, a new normal is taking shape around the world. “It still feels kind of incomplete,” said ...

All-in-one protection for you and your family's digital journey - across all devices and online experiences. Bitdefender was named a Leader in The Forrester Wave™: Endpoint Security, Q4 2023, a ...